107 related articles for article (PubMed ID: 9027615)
1. K-ras mutation in sputum of patients with or without lung cancer.
Ronai Z; Yabubovskaya MS; Zhang E; Belitsky GA
J Cell Biochem Suppl; 1996; 25():172-6. PubMed ID: 9027615
[TBL] [Abstract][Full Text] [Related]
2. K-ras mutation in sputum of primary lung cancer patients does not always reflect that of cancerous cells.
Nakajima E; Hirano T; Konaka C; Ikeda N; Kawate N; Ebihara Y; Kato H
Int J Oncol; 2001 Jan; 18(1):105-10. PubMed ID: 11115545
[TBL] [Abstract][Full Text] [Related]
3. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.
Chong IW; Chang MY; Sheu CC; Wang CY; Hwang JJ; Huang MS; Lin SR
Oncol Rep; 2007 Jul; 18(1):17-24. PubMed ID: 17549340
[TBL] [Abstract][Full Text] [Related]
4. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
Behn M; Qun S; Pankow W; Havemann K; Schuermann M
Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
[TBL] [Abstract][Full Text] [Related]
5. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer.
Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z
Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089
[TBL] [Abstract][Full Text] [Related]
6. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA).
Takeda S; Ichii S; Nakamura Y
Hum Mutat; 1993; 2(2):112-7. PubMed ID: 8318987
[TBL] [Abstract][Full Text] [Related]
8. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
9. [Detection of K-ras mutation from malignant cells in sputum with mutant-allele specific amplification (MASA) method].
Kimura S; Fukuchi K; Takeda S; Shin S; Saito D; Akamatsu S; Himeji Y; Chen GL; Watanabe H; Takagi Y
Rinsho Byori; 1995 Jul; 43(7):718-23. PubMed ID: 7674546
[TBL] [Abstract][Full Text] [Related]
10. Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China.
Keohavong P; Lan Q; Gao WM; Zheng KC; Mady HH; Melhem MF; Mumford JL
Carcinogenesis; 2005 Feb; 26(2):303-8. PubMed ID: 15564291
[TBL] [Abstract][Full Text] [Related]
11. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
[TBL] [Abstract][Full Text] [Related]
12. Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions.
Oshita F; Nomura I; Yamada K; Kato Y; Tanaka G; Noda K
Clin Cancer Res; 1999 Mar; 5(3):617-20. PubMed ID: 10100714
[TBL] [Abstract][Full Text] [Related]
13. [Detection of oncogenic mutations in sputum and its diagnostic value of lung cancer].
Wang L; Wang G; Xia X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr; 21(4):236-9. PubMed ID: 11326973
[TBL] [Abstract][Full Text] [Related]
14. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer.
Mao L; Hruban RH; Boyle JO; Tockman M; Sidransky D
Cancer Res; 1994 Apr; 54(7):1634-7. PubMed ID: 8137272
[TBL] [Abstract][Full Text] [Related]
15. Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas.
Urban T; Ricci S; Danel C; Antoine M; Kambouchner M; Godard V; Lacave R; Bernaudin JF
Br J Cancer; 2000 Jan; 82(2):412-7. PubMed ID: 10646897
[TBL] [Abstract][Full Text] [Related]
16. Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.
Lehman TA; Scott F; Seddon M; Kelly K; Dempsey EC; Wilson VL; Mulshine JL; Modali R
Anal Biochem; 1996 Aug; 239(2):153-9. PubMed ID: 8811898
[TBL] [Abstract][Full Text] [Related]
17. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
19. High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer.
Yakubovskaya MS; Spiegelman V; Luo FC; Malaev S; Salnev A; Zborovskaya I; Gasparyan A; Polotsky B; Machaladze Z; Trachtenberg AC
Int J Cancer; 1995 Dec; 63(6):810-4. PubMed ID: 8847139
[TBL] [Abstract][Full Text] [Related]
20. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
